Innovative Eyewear, Inc. (LUCY) 10-Year Financial Performance & Capital Metrics

LUCY • • Industrial / General

HealthcareMedical InstrumentsOphthalmic Devices & Vision CareContact Lenses & Vision Correction

AboutInnovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. The company sells its products through various e-commerce and retail distribution channels. Innovative Eyewear, Inc. has a partnership with Lucyd. The company was founded in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. operates as a subsidiary of Lucyd Ltd.Show more

Revenue $2M +42.0%
EBITDA -$8M -14.8%
Net Income -$8M -16.6%
EPS (Diluted) -5.19 +59.0%
Gross Margin 13.15% +227.0%
EBITDA Margin -475.07% +19.1%
Operating Margin -484.2% +18.6%
Net Margin -474.6% +17.9%
ROE -106% +23.8%
ROIC -153.61% +73.6%
Debt/Equity -
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 220.7%
✓Trading at only 0.3x book value

✗Weaknesses

✗Negative free cash flow
✗Shares diluted 100.0% in last year
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y220.74%

3Y33.31%

TTM53.22%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-22830.74%

EPS CAGR

10Y-

5Y-

3Y-

TTM-12302.08%

ROCE

10Y Avg-513.36%

5Y Avg-513.36%

3Y Avg-169.65%

Latest-107.84%

Peer Comparison

Contact Lenses & Vision Correction

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
COOThe Cooper Companies, Inc.	16.13B	82.31	44.02	5.06%	10.08%	4.88%	2.69%	0.34
LUCYInnovative Eyewear, Inc.	8.19M	1.53	-0.29	41.99%	-770.01%	-17.97%
BLCOBausch + Lomb Corporation	6.18B	17.44	-19.38	15.56%	-6.13%	-4.69%		0.75
STAASTAAR Surgical Company	1.04B	20.97	-51.15	-2.64%	-41.79%	-27.24%		0.10
WRBYWarby Parker Inc.	3B	28.33	-166.65	15.16%	0.08%	0.19%	1.16%	0.66

Profit & Loss

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	4.82K	57K	690.67K	659.79K	1.15M	1.64M
Revenue Growth %	-	10.82%	11.12%	-0.04%	0.75%	0.42%
Cost of Goods Sold+	7.74K	74.27K	542.42K	716.08K	1.27M	1.42M
COGS % of Revenue	1.6%	1.3%	0.79%	1.09%	1.1%	0.87%
Gross Profit+	-2.91K	-17.27K	148.25K	-56.29K	-119.33K	215.19K
Gross Margin %	-0.6%	-0.3%	0.21%	-0.09%	-0.1%	0.13%
Gross Profit Growth %	-	-4.93%	9.58%	-1.38%	-1.12%	2.8%
Operating Expenses+	106.51K	635.74K	3.35M	5.52M	6.74M	8.14M
OpEx % of Revenue	22.09%	11.15%	4.86%	8.37%	5.84%	4.97%
Selling, General & Admin	46.32K	468.85K	3.16M	4.86M	5.93M	7.18M
SG&A % of Revenue	9.61%	8.23%	4.57%	7.36%	5.15%	4.39%
Research & Development	4.08K	36.89K	86.26K	524.69K	662.18K	819.39K
R&D % of Revenue	0.85%	0.65%	0.12%	0.8%	0.57%	0.5%
Other Operating Expenses	56.11K	130K	109.97K	140K	140K	140K
Operating Income+	-109.43K	-653.01K	-3.21M	-5.58M	-6.86M	-7.92M
Operating Margin %	-22.7%	-11.46%	-4.64%	-8.45%	-5.95%	-4.84%
Operating Income Growth %	-	-4.97%	-3.91%	-0.74%	-0.23%	-0.16%
EBITDA+	-109.43K	-652.01K	-3.2M	-5.54M	-6.77M	-7.77M
EBITDA Margin %	-22.7%	-11.44%	-4.63%	-8.4%	-5.87%	-4.75%
EBITDA Growth %	-	-4.96%	-3.9%	-0.73%	-0.22%	-0.15%
D&A (Non-Cash Add-back)	0	994	7.68K	32.57K	85.26K	149.39K
EBIT	-109.43K	-763.22K	-3.21M	-5.58M	-6.66M	-7.77M
Net Interest Income+	0	-4.97K	-39.43K	-105.17K	-3.04K	0
Interest Income	0	0	0	0	0	0
Interest Expense	0	4.97K	39.43K	105.17K	3.04K	0
Other Income/Expense	0	-115.17K	-39.43K	-105.17K	192.11K	157.19K
Pretax Income+	-109.43K	-768.18K	-3.24M	-5.68M	-6.66M	-7.77M
Pretax Margin %	-22.7%	-13.48%	-4.7%	-8.61%	-5.78%	-4.75%
Income Tax+	0	0	0	0	0	0
Effective Tax Rate %	1%	1%	1%	1%	1%	1%
Net Income+	-109.43K	-768.18K	-3.24M	-5.68M	-6.66M	-7.77M
Net Margin %	-22.7%	-13.48%	-4.7%	-8.61%	-5.78%	-4.75%
Net Income Growth %	-	-6.02%	-3.22%	-0.75%	-0.17%	-0.17%
Net Income (Continuing)	-109.43K	-768.18K	-3.24M	-5.68M	-6.66M	-7.77M
Discontinued Operations	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0
EPS (Diluted)+	-2.64	-5.19	-12.37	-17.41	-12.67	-5.19
EPS Growth %	-	-0.97%	-1.38%	-0.41%	0.27%	0.59%
EPS (Basic)	-2.64	-5.19	-12.37	-17.41	-12.67	-5.19
Diluted Shares Outstanding	99.45K	148.01K	262.28K	326.45K	525.8K	1.5M
Basic Shares Outstanding	99.45K	148.01K	262.28K	326.45K	525.8K	1.5M
Dividend Payout Ratio	-	-	-	-	-	-

Balance Sheet

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	0	141.8K	644.33K	4.24M	5.62M	9.24M
Cash & Short-Term Investments	0	27.02K	79.73K	3.59M	4.29M	7.52M
Cash Only	0	27.02K	79.73K	3.59M	4.29M	2.63M
Short-Term Investments	0	0	0	0	0	4.9M
Accounts Receivable	0	0	43.39K	110.26K	93.21K	131.31K
Days Sales Outstanding	-	-	22.93	61	29.52	29.29
Inventory	0	89.78K	275.5K	94.7K	856.76K	831.76K
Days Inventory Outstanding	-	441.25	185.39	48.27	245.88	213.61
Other Current Assets	0	0	112.61K	36.24K	65.7K	59.45K
Total Non-Current Assets+	0	89.86K	179.99K	449.15K	601.99K	600.09K
Property, Plant & Equipment	0	0	20.28K	119.75K	132.85K	107.56K
Fixed Asset Turnover	-	-	34.05x	5.51x	8.68x	15.21x
Goodwill	0	0	0	0	0	0
Intangible Assets	0	69.21K	159.71K	247.63K	396.5K	451.3K
Long-Term Investments	0	20.65K	11.23K	0	0	0
Other Non-Current Assets	0	0	111.15K	81.78K	72.64K	41.23K
Total Assets+	0	231.66K	824.32K	4.69M	6.22M	9.84M
Asset Turnover	-	0.25x	0.84x	0.14x	0.19x	0.17x
Asset Growth %	-	-	2.56%	4.69%	0.33%	0.58%
Total Current Liabilities+	483.82K	765.85K	616.8K	600K	624.49K	737.72K
Accounts Payable	0	51.41K	167.05K	275.66K	581.99K	692.82K
Days Payables Outstanding	-	252.67	112.41	140.51	167.03	177.93
Short-Term Debt	0	599.54K	289.03K	61.36K	0	0
Deferred Revenue (Current)	0	0	0	30K	42.5K	44.9K
Other Current Liabilities	0	114.9K	160.72K	232.99K	0	0
Current Ratio	-	0.19x	1.04x	7.07x	8.99x	12.52x
Quick Ratio	-	0.07x	0.60x	6.91x	7.62x	11.40x
Cash Conversion Cycle	-	-	95.91	-31.24	108.38	64.97
Total Non-Current Liabilities+	0	0	0	65.45K	35.45K	5.45K
Long-Term Debt	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	0
Deferred Tax Liabilities	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0
Total Liabilities	483.82K	765.85K	616.8K	665.46K	659.94K	743.17K
Total Debt+	0	599.54K	289.03K	61.36K	0	0
Net Debt	0	572.52K	209.3K	-3.53M	-4.29M	-2.63M
Debt / Equity	-	-	1.39x	0.02x	-	-
Debt / EBITDA	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-
Interest Coverage	-	-131.50x	-81.28x	-53.02x	-2258.08x	-
Total Equity+	-483.82K	-534.19K	207.52K	4.02M	5.56M	9.1M
Equity Growth %	-	-0.1%	1.39%	18.39%	0.38%	0.64%
Book Value per Share	-4.87	-3.61	0.79	12.33	10.57	6.08
Total Shareholders' Equity	-483.82K	-534.19K	207.52K	4.02M	5.56M	9.1M
Common Stock	0	41	60	73	129	25
Retained Earnings	-611.46K	-1.38M	-4.62M	-10.31M	-16.97M	-24.74M
Treasury Stock	0	0	0	0	0	0
Accumulated OCI	0	0	-11.23K	0	0	0
Minority Interest	0	0	0	0	0	0

Cash Flow

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	0	-40.26K	-1.21M	-3.22M	-5.77M	-6.74M
Operating CF Margin %	-	-0.71%	-1.76%	-4.89%	-5%	-4.12%
Operating CF Growth %	-	-	-29.16%	-1.66%	-0.79%	-0.17%
Net Income	-109.43K	-768.18K	-3.24M	-5.68M	-6.66M	-7.77M
Depreciation & Amortization	0	994	7.68K	32.57K	85.26K	149.39K
Stock-Based Compensation	0	81.64K	1.33M	1.47M	936.77K	774.79K
Deferred Taxes	0	0	0	0	0	0
Other Non-Cash Items	109.43K	653.51K	868.87K	1.18M	238.89K	389.69K
Working Capital Changes	0	-8.22K	-181.13K	-230.78K	-363.79K	-286.98K
Change in Receivables	0	0	-43.39K	-183.09K	0	-4.57K
Change in Inventory	0	-29.67K	-250.44K	47.77K	0	-399.59K
Change in Payables	0	0	0	0	0	0
Cash from Investing+	0	-59.04K	-118.45K	-219.95K	-198.75K	-5.16M
Capital Expenditures	0	-59.04K	-20.78K	-121.56K	-78.46K	-62.2K
CapEx % of Revenue	-	1.04%	0.03%	0.18%	0.07%	0.04%
Acquisitions	-	-	-	-	-	-
Investments	-	-	-	-	-	-
Other Investing	0	0	-97.67K	-98.39K	-171.09K	-204.77K
Cash from Financing+	0	126.33K	1.39M	6.96M	6.66M	10.24M
Debt Issued (Net)	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-
Other Financing	0	0	-111.15K	6.68K	2.66M	3.65M
Net Change in Cash	-	-	-	-	-	-
Free Cash Flow+	0	-99.3K	-1.33M	-3.44M	-6.02M	-7.01M
FCF Margin %	-	-1.74%	-1.93%	-5.22%	-5.22%	-4.28%
FCF Growth %	-	-	-12.42%	-1.58%	-0.75%	-0.16%
FCF per Share	-	-0.67	-5.08	-10.55	-11.45	-4.68
FCF Conversion (FCF/Net Income)	-	0.05x	0.37x	0.57x	0.87x	0.87x
Interest Paid	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0

Key Ratios

Metric	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-1563.5%	-268.52%	-139.06%	-106%
Return on Invested Capital (ROIC)	-	-	-1056.28%	-917.72%	-582.28%	-153.61%
Gross Margin	-60.44%	-30.3%	21.47%	-8.53%	-10.35%	13.15%
Net Margin	-2269.8%	-1347.76%	-469.76%	-861.16%	-578.18%	-474.6%
Debt / Equity	-	-	1.39x	0.02x	-	-
Interest Coverage	-	-131.50x	-81.28x	-53.02x	-2258.08x	-
FCF Conversion	-	0.05x	0.37x	0.57x	0.87x	0.87x
Revenue Growth	-	1082.27%	1111.77%	-4.47%	74.67%	41.99%

Frequently Asked Questions

Growth & Financials

Innovative Eyewear, Inc. (LUCY) reported $2.4M in revenue for fiscal year 2024. This represents a 49528% increase from $0.0M in 2019.

Innovative Eyewear, Inc. (LUCY) grew revenue by 42.0% over the past year. This is strong growth.

Innovative Eyewear, Inc. (LUCY) reported a net loss of $1.84B for fiscal year 2024.

Dividend & Returns

Innovative Eyewear, Inc. (LUCY) has a return on equity (ROE) of -106.0%. Negative ROE indicates the company is unprofitable.

Innovative Eyewear, Inc. (LUCY) had negative free cash flow of $8.0M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener